
The civil rights leader Rev. Jesse Jackson has been hospitalized, the Rainbow PUSH Coalition announced Wednesday evening.
Jackson, 84, has been admitted to the hospital and is under observation for progressive supranuclear palsy, a neurodegenerative condition, which he has been managing for a decade, the organization said in a statement.
"The family appreciates all prayers at this time," the group said.
Jackson was originally diagnosed with Parkinson's disease, however his PSP condition was confirmed in April, the organization said.
PSP is a rare neurological disorder which affects body movements, walking and balance, and eye movements, according to the National Institutes of Health. It is caused by damage to nerve cells in parts of the brain.
Jackson, a protege to the Rev. Martin Luther King Jr. who rose to prominence as one of the nation's foremost civil rights leaders and twice ran for U.S. president, stepped down in 2023 from the leadership of the Rainbow PUSH Coalition, which he founded.
LATEST POSTS
- 1
'No Kings' protests live updates: More than 8 million turned out across all 50 states, organizers say - 2
Israel's haredi draft crisis: Court ruling and political stalemate reach breaking point - 3
Scientists document a death from a meat allergy tied to certain ticks - 4
At least 7 dead as Israel renews attacks on Beirut and across Lebanon - 5
Flu activity rises sharply across US with 7.5 million cases, CDC data shows
Moving Wedding Objections for Paramount Functions
Scientists are getting our robotic explorers ready to help send humans to Mars
Pedal Power: Divulging Well known Bike Brands for Each Cyclist
4 injured in shooting at North Carolina tree lighting ceremony
Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance
In blow to Lula, Brazil Congress revives controversial environmental bill
Instructions to Pick the Right Gold Speculation Procedure: Exploring the Market
Move. Cheer. Dance. Do the wave. How to tap into the collective joy of 'we mode'
Cannabis reclassification could 'open the floodgates' for research, scientists say













